Catalysts for a 2017 Biotech Bounce

The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), SPDR S&P Biotech ETF (NYSEArca: XBI) and other biotechnology exchange traded funds were punished last year with election year rhetoric widely seen as the primary catalyst behind the sector’s struggles. Healthcare stocks and ETFs...